Your browser doesn't support javascript.
loading
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer.
Patil, Namrata S; Nabet, Barzin Y; Müller, Sören; Koeppen, Hartmut; Zou, Wei; Giltnane, Jennifer; Au-Yeung, Amelia; Srivats, Shyam; Cheng, Jason H; Takahashi, Chikara; de Almeida, Patricia E; Chitre, Avantika S; Grogan, Jane L; Rangell, Linda; Jayakar, Sangeeta; Peterson, Maureen; Hsia, Allison W; O'Gorman, William E; Ballinger, Marcus; Banchereau, Romain; Shames, David S.
Afiliación
  • Patil NS; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA. Electronic address: patil.namrata@gene.com.
  • Nabet BY; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA. Electronic address: nabet.barzin@gene.com.
  • Müller S; Oncology Bioinformatics, Genentech, Inc., South San Francisco, CA, USA.
  • Koeppen H; Research Pathology, Genentech, Inc., South San Francisco, CA, USA.
  • Zou W; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.
  • Giltnane J; Research Pathology, Genentech, Inc., South San Francisco, CA, USA.
  • Au-Yeung A; OMNI Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.
  • Srivats S; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.
  • Cheng JH; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.
  • Takahashi C; OMNI Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.
  • de Almeida PE; Cancer Immunology Research, Genentech, Inc., South San Francisco, CA, USA.
  • Chitre AS; Cancer Immunology Research, Genentech, Inc., South San Francisco, CA, USA.
  • Grogan JL; Cancer Immunology Research, Genentech, Inc., South San Francisco, CA, USA.
  • Rangell L; Research Pathology, Genentech, Inc., South San Francisco, CA, USA.
  • Jayakar S; Research Pathology, Genentech, Inc., South San Francisco, CA, USA.
  • Peterson M; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.
  • Hsia AW; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.
  • O'Gorman WE; OMNI Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.
  • Ballinger M; Clinical Science, Genentech, Inc., South San Francisco, CA, USA.
  • Banchereau R; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.
  • Shames DS; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.
Cancer Cell ; 40(3): 289-300.e4, 2022 03 14.
Article en En | MEDLINE | ID: mdl-35216676
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article